It mimics a hormone in the body known as glucagon-like peptide-1 (GLP-1)
Therefore, identifying an optimized receptor potency ratio is crucial to harmonize efficacy and safety
Biomaterials and nanomedicine for bone regeneration: Progress and future prospects

Contact your healthcare provider promptly if you experience: Persistent dizziness lasting more than a few seconds when standing Fainting or near-fainting episodes Falls or loss of balance attributed to dizziness Chest pain, palpitations, or irregular heartbeat accompanying low blood pressure symptoms Severe or persistent nausea, vomiting, or diarrhea leading to dehydration Confusion, difficulty concentrating, or unusual fatigue Blood pressure readings consistently below 90/60 mmHg with symptoms New or worsening shortness of breath Seek emergency care (call 911) if you experience: Loss of consciousness Chest pain or pressure Severe shortness of breath Confusion or altered mental status Seizures Signs of stroke (facial drooping, arm weakness, speech difficulty) Your healthcare provider may need to adjust your GLP-1 medication dose, modify or discontinue antihypertensive medications, or investigate other potential causes of hypotension

Understanding how to manage these localized reactions ensures that skin sensitivity does not become a barrier to your long-term metabolic goals
A recent clinical trial found that semaglutide (Ozempic/Wegovy) was associated with a substantial reduction in heavy alcohol consumption among individuals with alcohol use disorder (AUD) and obesity, while also supporting weight loss